September 2019 Shareholder Newsletter

Kazia Therapeutics is pleased to make its September 2019 newsletter available to investors.


Kazia wins ANZLF Trans-Tasman Innovation & Growth Award

Kazia has been named as a winner in the 2019 Australian and New Zealand Leadership Forum (ANZLF) Trans-Tasman Innovation & Growth Awards.


Dr James Garner presents at the 2019 Gold Coast Investment Showcase

Our CEO, Dr James Garner recently presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase.